Marriage Counselors in Port Jefferson, NY Accepting Medicare

7 Marriage Counselors found. Showing 1 - 7

Kelly Conrad Sanchez, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Main St, Port Jefferson, NY 11777 Phone: 631-296-1113

Susanne Carmello, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 29 Laurel Dr, Port Jefferson, NY 11777 Phone: 631-681-9938

Avneet Kaur Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Main St, Port Jefferson, NY 11777 Phone: 631-296-1113

Michelle K Wiley Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Main St, Port Jefferson, NY 11777 Phone: 516-993-6678

Mrs. Rachel Stein, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 49 Hillcrest Ave, Port Jefferson, NY 11777 Phone: 631-965-7465

Regina Mcguire, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Main St, Port Jefferson, NY 11777 Phone: 631-296-1113

Ms. Lindsey Mercedes Echevarria, MFT-LP Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Main St, Port Jefferson, NY 11777 Phone: 516-993-6678    Fax: 855-425-7986

News Archive

Testicular cancer survivors with low testosterone more likely to have chronic health problems

In a large study, 38% of 491 testicular cancer survivors had low testosterone levels, known as hypogonadism.

China Jo-Jo Drugstores fourth-quarter revenues up 39.6% to $16.3 million

China Jo-Jo Drugstores, Inc., which operates a retail pharmacy chain in the People's Republic of China, today reported full and fourth quarter financial results for the fiscal year ended March 31, 2010.

Tibotec reports Phase 3 trial results of TMC278 vs. EFV in treatment-naive HIV-1-infected adults

Tibotec Pharmaceuticals announced today results from two pivotal Phase 3, double-blind, randomized clinical trials comparing the efficacy, safety and tolerability of its investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) TMC278 (rilpivirine) versus efavirenz (EFV), each administered once daily with a nucleoside/nucleotide background regimen in treatment-naive, HIV-1-infected adults.

Philadelphia jury returned $13.5 million verdict against Johnson & Johnson's Ethicon subsidiary

Legal-Bay LLC, The Lawsuit Settlement Funding Company, reported today that a Philadelphia jury returned a $13.5 million verdict against Johnson & Johnson's Ethicon subsidiary on Wednesday, making this the second substantial verdict award in favor of the plaintiffs in recent months.

Read more Medical News

› Verified 6 days ago